Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3114413
Max Phase: Preclinical
Molecular Formula: C15H26ClNO4
Molecular Weight: 283.37
Molecule Type: Small molecule
Associated Items:
ID: ALA3114413
Max Phase: Preclinical
Molecular Formula: C15H26ClNO4
Molecular Weight: 283.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.NCc1c(OCCCCO)cccc1OCCCCO
Standard InChI: InChI=1S/C15H25NO4.ClH/c16-12-13-14(19-10-3-1-8-17)6-5-7-15(13)20-11-4-2-9-18;/h5-7,17-18H,1-4,8-12,16H2;1H
Standard InChI Key: KMIKWUOAHJQLHF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 283.37 | Molecular Weight (Monoisotopic): 283.1784 | AlogP: 1.45 | #Rotatable Bonds: 11 |
Polar Surface Area: 84.94 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.23 | CX LogP: 0.56 | CX LogD: -0.32 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.54 | Np Likeness Score: 0.10 |
1. Lucchesini F, Pocci M, Alfei S, Bertini V, Buffoni F.. (2014) Synthesis of 2,6-disubstituted benzylamine derivatives as reversible selective inhibitors of copper amine oxidases., 22 (5): [PMID:24529308] [10.1016/j.bmc.2014.01.037] |
Source(1):